Edition:
United States

Ablynx NV (ABLX.BR)

ABLX.BR on Brussels Stock Exchange

43.96EUR
21 Feb 2018
Change (% chg)

€0.00 (+0.00%)
Prev Close
€43.96
Open
€43.86
Day's High
€44.00
Day's Low
€43.86
Volume
243,120
Avg. Vol
607,953
52-wk High
€45.16
52-wk Low
€10.26

Select another date:

Fri, Feb 16 2018

BRIEF-Ablynx Announces Option Exercise By Sanofi To License Two Additional Target Combinations​

* ABLYNX ANNOUNCES OPTION EXERCISE BY SANOFI FOR TWO ADDITIONAL MULTI-SPECIFIC NANOBODY PRODUCT CANDIDATES

Sanofi beats Novo to buy Ablynx for $4.8 billion in biotech M&A boom

PARIS/LONDON French drugmaker Sanofi has agreed to buy Belgian biotech company Ablynx for 3.9 billion euros ($4.8 billion), beating Novo Nordisk and marking its second big deal this month after buying Bioverativ. | Video

UPDATE 4-Sanofi beats Novo to buy Ablynx for $4.8 bln in biotech M&A boom

* Novo Nordisk concedes defeat, seeks other bolt-on deals (Adds cumulative M&A value, debt cost, link to Novo Nordisk interview)

LIVE MARKETS-Closing snapshot: STOXX 600 edges lower

* European shares dip * Heavy earnings week begins * AMS soars after raising outlook, doubling revenue * Sanofi buys Ablynx for 3.9 bln euros, Ablynx +20% Jan 29 Welcome to the home for real time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Helen Reid. Reach her on Messenger to share your thoughts on market moves: helen.reid.thomsonreuters.com@reuters.net CLOSING SNAPSHOT: STOXX 600 EDGES LOWER (163

LIVE MARKETS-How much would yields need to rise to cause equities pain?

* European shares dip * Heavy earnings week begins * AMS soars after raising outlook, doubling revenue * Sanofi buys Ablynx for 3.9 bln euros, Ablynx +20% Jan 29 Welcome to the home for real time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Helen Reid. Reach her on Messenger to share your thoughts on market moves: helen.reid.thomsonreuters.com@reuters.net HOW MUCH WOULD YIELDS NEED TO RISE TO CAUSE

LIVE MARKETS-"Tech won't go out of fashion"

* European shares dip * Heavy earnings week begins * AMS soars after raising outlook, doubling revenue * Sanofi buys Ablynx for 3.9 bln euros, Ablynx +20% Jan 29 Welcome to the home for real time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Helen Reid. Reach her on Messenger to share your thoughts on market moves: helen.reid.thomsonreuters.com@reuters.net "TECH WON'T GO OUT OF FASHION" (1507 GMT)

LIVE MARKETS-Six positives for global financials

* European shares dip after flat start * Heavy earnings week begins * AMS soars after raising outlook, doubling revenue * Sanofi buys Ablynx for 3.9 bln euros, Ablynx +20% Jan 29 Welcome to the home for real time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Helen Reid. Reach her on Messenger to share your thoughts on market moves: helen.reid.thomsonreuters.com@reuters.net SIX POSITIVES FOR GLOBAL FI

LIVE MARKETS-Spiking bund yields: a sign of "clouds" gathering?

* European shares dip after flat start * Heavy earnings week begins * AMS soars after raising outlook, doubling revenue * Sanofi buys Ablynx for 3.9 bln euros, Ablynx +20% Jan 29 Welcome to the home for real time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Helen Reid. Reach her on Messenger to share your thoughts on market moves: helen.reid.thomsonreuters.com@reuters.net SPIKING BUND YIELDS: A S

BRIEF-Sanofi CFO sees cost of debt to finance Ablynx acquisition around 1 pct

Jan 29 Sanofi Chief Financial Officer Jerome Contamine says:

LIVE MARKETS-With bond yields rising, is it time for value investing?

* European shares dip after flat start * Heavy earnings week begins * AMS soars after raising outlook, doubling revenue * Sanofi buys Ablynx for 3.9 bln euros, Ablynx +20% Jan 29 Welcome to the home for real time coverage of European equity markets brought to you by Reuters stocks reporters and anchored today by Helen Reid. Reach her on Messenger to share your thoughts on market moves: helen.reid.thomsonreuters.com@reuters.net WITH BOND YIELDS RISING, IS

Select another date: